ALBANY INTERNATIONAL CORP /DE/ — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ALBANY INTERNATIONAL CORP /DE/ filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $257.70M | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | $271.10M | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | $273.90M | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | $251.40M | Feb 28, 2020 |
| FY2019 | Dec 31, 2018 | $251.60M | Feb 28, 2020 |
| FY2019 | Sep 30, 2018 | $251.90M | Feb 28, 2020 |
| FY2019 | Jun 30, 2018 | $255.40M | Feb 28, 2020 |
| FY2019 | Mar 31, 2018 | $223.60M | Feb 28, 2020 |
| FY2019 | Dec 31, 2017 | $226.70M | Feb 28, 2020 |
| FY2019 | Sep 30, 2017 | $222.10M | Feb 28, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.18B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.23B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.15B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $1.03B | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $929.24M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $900.61M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $1.05B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $982.48M | Feb 25, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $243.92M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $401.78M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $423.72M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $389.78M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $378.39M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $371.07M | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | $96.60M | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | $104.10M | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | $105.20M | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | $91.80M | Feb 28, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($57.34M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $87.62M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $111.12M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $95.76M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $118.48M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $98.59M | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | $29.10M | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | $40.00M | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | $34.10M | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | $29.20M | Feb 28, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($36.10M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $131.36M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $167.89M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $181.02M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $178.01M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $166.08M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $193.58M | Feb 25, 2022 |
| FY2018 | Dec 31, 2018 | $37.40M | Mar 14, 2019 |
| FY2018 | Sep 30, 2018 | $40.80M | Mar 14, 2019 |
| FY2018 | Jun 30, 2018 | $42.20M | Mar 14, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $40.60M | Feb 26, 2024 |
| FY2023 | Dec 31, 2022 | $39.90M | Feb 26, 2024 |
| FY2023 | Dec 31, 2021 | $38.90M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $25.80M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $26.90M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $29.80M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $30.70M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $28.80M | Mar 14, 2019 |
| FY2017 | Dec 31, 2015 | $31.70M | Feb 28, 2018 |
| FY2016 | Dec 31, 2014 | $32.40M | Mar 1, 2017 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $218.33M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $210.88M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $214.92M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $168.71M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $160.13M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $163.91M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $163.65M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $156.19M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $162.94M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $158.36M | Mar 14, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $152.47M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $218.44M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $148.06M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $128.21M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $217.48M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $140.25M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $200.35M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $132.49M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $64.22M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $80.94M | Mar 14, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $69.83M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $80.25M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $83.56M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $93.68M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $52.79M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $41.46M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $67.36M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $81.58M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $85.51M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $71.24M | Mar 14, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.72B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.65B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.84B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $1.64B | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $1.56B | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $1.55B | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $1.47B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $1.42B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $1.36B | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $1.26B | Mar 14, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $986.61M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $699.75M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $867.69M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $774.71M | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | $678.46M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $730.07M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $771.68M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $809.71M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $788.18M | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $752.14M | Feb 28, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $726.21M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $943.54M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $961.37M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $863.05M | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | $873.97M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $816.07M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $698.68M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $605.25M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $569.77M | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $507.52M | Feb 28, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $162.51M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $176.26M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $180.18M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $178.22M | Feb 26, 2024 |
| FY2023 | Dec 31, 2021 | $182.12M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $187.55M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $180.93M | Feb 25, 2022 |
| FY2019 | Nov 20, 2019 | $17.30M | Feb 28, 2020 |
| FY2020 | Dec 31, 2018 | $164.38M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $166.80M | Feb 28, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $976.37M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.07B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.01B | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $931.32M | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | $863.06M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $770.75M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $698.50M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $589.65M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $534.08M | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $522.86M | Feb 28, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $112.35M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $115.28M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $173.42M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $291.78M | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | $302.04M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $241.32M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $195.54M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $197.76M | Feb 28, 2020 |
| FY2019 | Dec 31, 2017 | $183.73M | Feb 28, 2020 |
| FY2019 | Dec 31, 2016 | $181.74M | Feb 28, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $455.66M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $318.53M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $456.89M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $439.00M | Feb 26, 2024 |
| FY2021 | Dec 31, 2021 | $350.00M | Feb 25, 2022 |
| FY2021 | Dec 31, 2020 | $398.01M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $424.03M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $524.93M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $515.92M | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $484.58M | Feb 28, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | 3 | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | 1 | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | 1 | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 28, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | 3 | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | 1 | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | 1 | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 28, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 31.10M | Feb 26, 2025 |
| FY2024 | Dec 31, 2023 | 31.20M | Feb 26, 2025 |
| FY2024 | Dec 31, 2022 | 31.10M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | 32.10M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | 32.30M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | 32.30M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | 32.30M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | 32.20M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | 32.10M | Mar 14, 2019 |
| FY2017 | Dec 31, 2015 | 32.00M | Feb 28, 2018 |